- Home
- ZURA vs VNRX Comparison
ZURA vs VNRX Comparison
Compare ZURA & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- VNRX
- Stock Information
- Founded
- ZURA 2022
- VNRX N/A
- Country
- ZURA United States
- VNRX United States
- Employees
- ZURA N/A
- VNRX N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZURA Health Care
- VNRX Health Care
- Exchange
- ZURA Nasdaq
- VNRX Nasdaq
- Market Cap
- ZURA 61.9M
- VNRX 52.4M
- IPO Year
- ZURA N/A
- VNRX N/A
- Fundamental
- Price
- ZURA $1.13
- VNRX $0.80
- Analyst Decision
- ZURA Buy
- VNRX Strong Buy
- Analyst Count
- ZURA 7
- VNRX 5
- Target Price
- ZURA $14.33
- VNRX $3.88
- AVG Volume (30 Days)
- ZURA 545.9K
- VNRX 308.2K
- Earning Date
- ZURA 08-08-2025
- VNRX 08-13-2025
- Dividend Yield
- ZURA N/A
- VNRX N/A
- EPS Growth
- ZURA N/A
- VNRX N/A
- EPS
- ZURA N/A
- VNRX N/A
- Revenue
- ZURA N/A
- VNRX $1,308,361.00
- Revenue This Year
- ZURA N/A
- VNRX $563.72
- Revenue Next Year
- ZURA N/A
- VNRX $160.43
- P/E Ratio
- ZURA N/A
- VNRX N/A
- Revenue Growth
- ZURA N/A
- VNRX 64.16
- 52 Week Low
- ZURA $0.97
- VNRX $0.40
- 52 Week High
- ZURA $5.07
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- ZURA 45.37
- VNRX 75.61
- Support Level
- ZURA $1.10
- VNRX $0.40
- Resistance Level
- ZURA $1.37
- VNRX $0.75
- Average True Range (ATR)
- ZURA 0.09
- VNRX 0.08
- MACD
- ZURA 0.00
- VNRX 0.02
- Stochastic Oscillator
- ZURA 37.18
- VNRX 69.33
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.